These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7688897)

  • 21. Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA.44 and other antibodies.
    Ohsawa M; Kanno H; Machii T; Aozasa K
    J Clin Pathol; 1994 Oct; 47(10):928-32. PubMed ID: 7962607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
    Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
    Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.
    Werner M; von Wasielewski R; Bernhards J; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):411-6. PubMed ID: 2156377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.
    Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
    Pathobiology; 2011; 78(4):201-9. PubMed ID: 21778787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.
    Girling A; Caleffi M; King RJ; Millis RR
    J Clin Pathol; 1988 Apr; 41(4):448-53. PubMed ID: 2835402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peanut lectin agglutinin and alpha-lactalbumin. Binding and immunohistochemical localization in breast tissues.
    Lloyd RV; Foley J; Judd WJ
    Arch Pathol Lab Med; 1984 May; 108(5):392-5. PubMed ID: 6324715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.
    Vowden P; Lowe AD; Lennox ES; Bleehen NM
    Br J Cancer; 1986 Mar; 53(3):313-9. PubMed ID: 3516191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.
    Wong SY; Purdie AT; Han P
    Am J Pathol; 1992 Jun; 140(6):1473-82. PubMed ID: 1351369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
    Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
    Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraffin immunoreactivity of CD10, CDw75, and Bcl-6 in follicle center cell lymphoma.
    Dunphy CH; Polski JM; Lance Evans H; Gardner LJ
    Leuk Lymphoma; 2001 May; 41(5-6):585-92. PubMed ID: 11378576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
    Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma.
    Nakagoe T; Fukushima K; Hirota M; Kusano H; Kawahara K; Ayabe H; Tomita M; Kamihira S
    Jpn J Cancer Res; 1991 May; 82(5):559-68. PubMed ID: 1905702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis.
    Schmitt FC; Figueiredo P; Lacerda M
    Virchows Arch; 1995; 427(3):251-8. PubMed ID: 7496593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
    Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
    J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.
    Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU
    Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
    Dall'Olio F; Chiricolo M; Mariani E; Facchini A
    Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.